The largest database of trusted experimental protocols

299 protocols using phenylephrine

1

Aortic Vascular Function Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The thoracic aorta was dissected and placed in cold physiological buffer: 119 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2 × 2H2O, 1.17 mM MgSO4 × 7H2O, 20 mM NaHCO3, 1.18 mM KH2PO4, 0.027 mM EDTA, 10.5 mM glucose; bubbled with a mixture of 95% O2 and 5% CO2, resulting in pH 7.4. Aortic rings (2–3 mm) were mounted onto a multichamber isometric myograph system (Model 620M, Danish Myo Technology) and equilibrated at 37°C. The resting tension was reached by the normalization process using the ADInstuments Normalization module, where the segments of aorta were normalized to their length and diameter. At the beginning of each experiment, the ability of the preparation to develop a contraction was assessed by exposing the aorta segments to a high KCl solution (124 mM). Endothelium-dependent relaxations were determined by administration of cumulatively increasing concentrations of acetylcholine (10–9 to 10–5 M, MilliporeSigma) to aortas precontracted with phenylephrine (10–10 to 10–6 M, MilliporeSigma). The aorta segments were then washed 3 times every 10 minutes for 30 minutes. The endothelium-independent relaxation was tested by sodium nitroprusside (SNP, 0.1 nM to 10 μM, Merck), following precontraction with phenylephrine (10 μM, MilliporeSigma). Data were recorded and analyzed with the LabChart Pro evaluation program (ADInstruments).
+ Open protocol
+ Expand
2

Vascular Reactivity Measurement in Mouse Aorta and Mesenteric Arteries

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy mice were sacrificed by pentobarbital administration (100 mg/kg i.p.), and the thoracic aorta and mesenteric arteries were immediately collected. The vessels were placed in 6-well culture plates with RPMI and incubated with 10 μg of isolated mouse NETs with or without mLR12 (25 mg/ml). Three hours after stimulation, the vessels were placed in an ice-cold physiological salt solution composed of 130 mM NaCl, 14.9 mM NaHCO3, 3.7 mM KCl, 1.2 mM MgSO4, 2.5 mM CaCl2, 1.2 mM KH2PO4, and 5.5 mM glucose. Two-millimeter-long rings were cut and mounted on a 40 μm stainless-steel wire in a small vessel myograph (EMKA Technologies, France). The preparation was supplied with a carbogen gas mixture (95% O2, 5% CO2). After an equilibration period (at least 20 min) under optimal passive tension, two successive contractions in response to the combination of KCl depolarization and phenylephrine (Sigma, St. Louis, MO, USA) were used to measure the maximal contractile capacity of the vessels. Concentration–response curves to phenylephrine (1 nM to 100 μM) were obtained. After a washout period of 20 min, the vessels were precontracted with phenylephrine (1 μM) to 80% of the maximum contraction, and the acetylcholine (Sigma, St. Louis, MO, USA) concentration–response curve was obtained (1 nM to 100 μM).
+ Open protocol
+ Expand
3

Thoracic Aorta Vascular Function Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The thoracic aortas were removed and placed in cold Krebs solution, cleaned of fat and loose connective tissue, and sectioned into 4-mm-long rings. The sectioned rings were mounted on stainless steel hooks and suspended in 10-mL tissue baths. The bath was filled with Krebs solution (at 37°C, pH 7.4, with 95% O2/5% CO2) of the following compositions (mm): NaCl 120, KCl 5.5, MgCl2∙6H2O 1.2, NaH2PO4 1.2, CaCl2 2.5, NaHCO3 20, and glucose 10. The preload was 0.75 g, and the rings were equilibrated for 60 min. The Krebs buffer solution in the tissue bath was replaced every 15 min. At the end of the equilibration period, the maximal force generated by addition of 3 × 10−6m phenylephrine (Sigma-Aldrich) was determined. To evaluate endothelium-dependent relaxations, the rings were preconstricted with phenylephrine (3 × 10−6m) to obtain a stable plateau and then a cumulative dose–response curve to acetylcholine (10−9 to 10−4m; Sigma-Aldrich) was obtained. The NO-donor sodium nitroprusside (10−10 to 10−5m; Sigma-Aldrich) was added to examine endothelium-independent relaxations.
+ Open protocol
+ Expand
4

Mesenteric Artery Contractility Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rings of second-order mesenteric arteries were isolated to measure contractile responses. Mesenteric arteries were mounted in a Mulvany-style small vessel myograph (Danish Myo Technology, Denmark) containing Krebs-bicarbonate buffer (in mmol/L: D-glucose 11.1, CaCl2 2.5, NaCl 118, KCl 4.5, KH2PO4 1.03, MgSO4 0.45, NaHCO3 25) and bubbled with carbogen (95% O2, 5% CO2) to measure isometric tension. Two arteries from each animal were mounted and their responses were averaged. After 20 min equilibration, arteries were stretched to a resting tension of ~2 mN, contracted with KPSS and then maximally contracted with U46619 (U-max, 300 nM, Cayman Chemical, USA). Cumulative concentration-response curves to Ang II, phenylephrine (Sigma Aldrich, USA) and U46619 were obtained with a 20 min washout period between each curve. In another set of experiments, the curves to Ang II, phenylephrine and U46619 were constructed in the absence and presence of L-nitro-arginine methyl ester (L-NAME, 300 μM, Sigma Aldrich, USA), indomethacin (3 μM, Sigma Aldrich, USA), tempol (1 mM, Sigma Aldrich, USA) or tempol (1 mM) + catalase (2500 U/ml, Sigma Aldrich, USA). Each of these drugs was pre-incubated for 30 min before each curve. Responses were expressed as a percentage of the U-max.
+ Open protocol
+ Expand
5

Hypoxia-induced Pulmonary Vascular Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 1-hour surgery followed by a 23-hour recovery, the rats in each group (sham, ischemia with or without vagotomy) were anesthetized, the brains removed, and sectioned. Then, the animals were divided into two subgroups. The first subgroup was used for the isolated lung measurements in which the PAP and lung weight were continuously recorded throughout the experiments. Lungs were first ventilated with normoxic gas for during 30 minutes of the steady-state period, followed by the ventilation with hypoxic gas for 10 minutes in the presence of phenylephrine 30 μM phenylephrine (Sigma, Germany). 20 (link)The mean values of the PAP changes (∆PAP) during minutes 5-10 of hypoxic maneuver was considered as the response of pulmonary vasculature to hypoxia. In the second subgroup, arterial blood was taken from the femoral artery to analyze the blood gas parameters (Medica, Easy blood gas, USA). Finally, the animals were sacrificed under deep anesthesia. The chest was opened and the lower parts of the right and left lung sectioned and stored at -70 °C for the MDA measurement.
+ Open protocol
+ Expand
6

Preparation of Pharmacological Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cisplatin, phenylephrine, carbachol, and sodium nitroprusside were obtained from Sigma (Sigma Chemical Company, Poole, Dorset, UK).
phenylephrine, carbachol, and sodium nitroprusside were dissolved in distilled water. Cisplatin was dissolved in saline (0.9% NaCl).
+ Open protocol
+ Expand
7

Myography of Ovine Myometrial Vessels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Segments of myometrial resistance vessels from each sheep were mounted on a wire myograph system (Multi Myograph System 610 M; Danish Myo Technology A/S, Aarhus, Denmark) and normalized within 8 hours of dissection, as previously described. 24 (link) Vessels were constricted with phenylephrine (10 μmol/L; Sigma-Aldrich, Auckland, New Zealand) to confirm viability, washed, and equilibrated with physiological saline solution for 20 minutes. A second dose of phenylephrine (10 μmol/L) was given, and constriction was allowed to plateau before giving a single dose of acetylcholine (10 μmol/L; Sigma-Aldrich) to confirm endothelial integrity. After a further washout and 30-minute equilibration September 2016 period, a concentration-response curve to phenylephrine was constructed (0.1-10 μmol/L). The EC 80 concentration was calculated for individual vessels and used to preconstrict the arteries to construct concentration-response curves to acetylcholine (0.1-10 µmol/L) and then sodium nitroprusside (0.1-10 μmol/L; Sigma-Aldrich). Finally, a 120 mmol/L potassium solution (potassium physiological saline solution; HEPES, 10 mmol/L; NaCl, 24 mmol/L; KCl, 124 mmol/L; MgSO 4 , 2.4 mmol/L; CaCl 2 , 4.9 mmol/L; KH 2 PO 4 , 1.18 mmol/L; glucose, 5.5 mmol/L; pH, 7.4) was added to each vessel, and the constriction was allowed to plateau.
+ Open protocol
+ Expand
8

Vascular Reactivity Assessment in Arteries

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human arteries and mouse aortas were cut into 2 mm rings and mounted in an organ bath system (Danish Myo Technology 750TOBS or 610M myograph) (56 (link)). Following preconstriction with 120 mM KCl, arteries were constricted with phenylephrine (up to 60%–70% of maximal determined constriction) (MilliporeSigma), and vasorelaxant responses to increasing doses of Ach (1 nM to 10 μM, MilliporeSigma) and SNP (1 nM–10 μM, MilliporeSigma) were examined. Endothelium-dependent vasorelaxation in response to ACh was also studied in the presence of NAC (1 mM), l-NAME (100 μM, MilliporeSigma), Y27632 (10 μM, Cayman Chemical), or GKT137831 (10 μM, Cayman Chemical).
+ Open protocol
+ Expand
9

Vascular Reactivity Regulatory Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NO synthase (NOS) inhibitor Nω-nitro-L-arginine methyl ester (L-NAME), the endothelial muscarinic agonist acetylcholine, and the non-selective COX-inhibitor indomethacin, the EP3 receptor antagonist L798106, and the α1-adrenergic agonist phenylephrine were purchased from Millipore Sigma (St Louis, MO, United States). PGI2, the IP antagonist CAY10441, and the TP receptor antagonist SQ29548 were bought from Cayman Chemical (Ann Arbor, MI). L-NAME, phenylephrine, and acetylcholine were dissolved in distilled water, while PGI2 was dissolved in carbonate buffer (50 mM; pH 10.0). indomethacin, L79816, and SQ29548 were dissolved in DMSO at 2,000-fold working concentration (the final concentration of DMSO was 0.05/100, v/v). Concentrations of indomethacin, L79816, CAY10441 and SQ29548 were used according to our previous reports, in which these inhibitors were able to abolish the effects of intended targets (Liu et al., 2012a (link), 2017 (link); Li et al., 2016 (link), 2017 (link)).
The compositions of physiological salt solution (PSS; pH 7.4 with 95%O2-5% CO2) were as follows (in mM): NaCl 123, KCl 4.7, NaHCO3 15.5, KH2PO4 1.2, MgCl2 1.2, CaCl2 1.25, and D-glucose 11.5. The 60 mM K+-PSS (K+) was prepared by replacing an equal molar of NaCl with KCl.
+ Open protocol
+ Expand
10

Smooth Muscle Contractility Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals were of reagent grade or higher, and unless otherwise stated were purchased from Millipore-Sigma (Etobicoke, ON) or VWR (Mississauga, ON). Antibodies were obtained from Santa Cruz Biotechnology (Dallas, TX: anti-LC20, sc-15370; anti-MYPT1, H-130), Abcam (Toronto, ON: anti-smooth muscle α-actin, ab7817; anti-MLCK, ab76092), Millipore-Sigma (anti-CPI-17, 07–344), Chemicon (Temecula, CA: horseradish peroxidase (HRP)-coupled donkey anti-rabbit IgG). The ROCK inhibitor, GSK269962A (PubChem CID: 16095342), was acquired from Alexis Biochemicals (San Diego, CA). Bradykinin, phenylephrine, phorbol 12,13-dibutyrate (PDBu), and the PKC inhibitor GF109203x (PubChem CID: 2396) were purchased from Millipore-Sigma.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!